Oakridge International Limited (ASX:OAK)

Oakridge International Limited's half-year financial report for the period ending 31 December 2025 shows a significant improvement with a profit after tax of $172,239 compared to a loss of $126,968 in the previous half-year. Revenue from ordinary activities increased by 61.9% to $1,789,640. The company did not declare any dividends for the period. The report highlights the company's focus on healthcare technology, particularly through its subsidiary JCT Healthcare Pty Ltd, and its involvement in technology development focusing on IoT. The financial position as of 31 December 2025 indicates total assets of $2,110,536 and net assets of $1,074,485. The company also secured a short-term interest-free advance of $215,000 from an entity associated with a director. Despite cash outflows from operations impacting cash reserves, the directors believe the company remains a going concern due to expected profitability and ability to raise capital. The company's strategic focus includes strengthening its capital base, expanding its market reach, and enhancing its product offerings.